Industry news

Cytokine Storm Syndrome and COVID-19

Pre-Recorded Webinar

Cytokine Storm Syndrome and COVID-19


COVID-19 Test
At The End of This Activity, Participants Will Be Able to:
  • Recognize the variety of conditions that can be complicated by cytokine storm syndrome.
  • Calculate the probability of a cytokine storm syndrome using various proposed criteria.
  • Compare and contrast the various treatment modalities available for cytokine storm syndrome.
Activity Details:
Date: May 27, 2020

Time: 1-2 PM Eastern

Price: FREE


Cytokine storm syndrome (CSS) in an umbrella term for a potentially fatal immune response associated with a variety of conditions and triggers. It is known by many names, including macrophage activation syndrome (MAS) when associated with rheumatic diseases, or familial hemophagocytic lymphohistiocytosis (HLH) as a genetic condition that most often affect infants.

Many common forms of CSS are often triggered by infections, particularly viruses, of which COVID-19 appears to be included.

In this webinar, Dr. Randy Cron will discuss criteria for identifying CSS in patients, complications, and available treatments which include glucocorticoids, but also targeted therapies that dampen pro-inflammatory cytokines like interleukin-1 (IL-1) and IL-6.

Register Today
Randy Cron
Randy Cron, MD, PhD

Professor of Pediatrics & Medicine
Director, Division of Pediatric Rheumatology
Children’s Hospital of Alabama/
University of Alabama at Birmingham

Supported by:
Siemens Healthineers
Learn more about AACC >  |  Join / Renew  |  Meetings  |  Publications  |  Artery
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

Quis autem vel eum iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur, vel illum qui dolorem?

Temporibus autem quibusdam et aut officiis debitis aut rerum necessitatibus saepe eveniet.

© 2006-2016 ACCLMU. Atlaskit.

To Top